Phathom to present Voquezna data at ACG 2026 meeting
Tweet Send to a Friend
Phathom Pharmaceuticals (Nasdaq: PHAT) will present three scientific posters on its drug Voquezna (vonoprazan) at the American College of Gastroenterology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




